Cannabis use linked to 37% higher stroke risk in massive study

Stroke remains a formidable global health challenge, consistently ranking as the third leading cause of death and disability combined worldwide. Each year, an estimated 12.2 million new strokes occur, and approximately 6.5 million people die from the condition. Beyond mortality, stroke is a leading cause of long-term disability, leaving millions with impaired mobility, speech difficulties, cognitive deficits, and a diminished quality of life. The economic burden is equally staggering, encompassing direct healthcare costs, rehabilitation expenses, and indirect costs from lost productivity and caregiver support. While many major risk factors for stroke are well-established and modifiable through lifestyle choices—such as maintaining a healthy diet, engaging in regular physical activity, managing blood pressure and cholesterol, and avoiding smoking—the role of recreational drug use has increasingly come under scrutiny as a significant, yet often overlooked, contributor.

The landscape of recreational drug use is vast and complex, with millions worldwide regularly engaging with various substances. In 2024, statistics from England and Wales indicated that 8.8% of adults aged 16 to 59—roughly 2.9 million people—reported using a legal or illegal recreational drug in the preceding year. Across the Atlantic, recent data from the United States reveals an even broader prevalence, with more than half of individuals over the age of 12 having used substances like cocaine, cannabis, or opiates at least once in their lifetime. These figures underscore the pervasive nature of drug use, highlighting the imperative for a deeper understanding of its potential health consequences, particularly concerning life-altering conditions like stroke. As societal attitudes toward certain substances, especially cannabis, evolve and legalization becomes more widespread in various regions, the need for robust scientific evidence regarding their health impacts grows increasingly critical.

Unraveling the Causal Link: Drugs and Stroke Risk

Prior research has progressively hinted at a connection between recreational drug use and an elevated risk of stroke. However, much of this evidence has been derived from observational studies, which, while valuable for identifying potential correlations, are inherently limited in their ability to establish causality. The challenge lies in disentangling whether the drugs themselves directly increase stroke risk or if the observed association is merely a reflection of other confounding factors. For instance, individuals who use recreational drugs might also share common characteristics or engage in other behaviors—such as poor diet, lack of exercise, smoking, excessive alcohol consumption, or pre-existing health conditions—that independently contribute to stroke risk. Without robust methodologies, it becomes difficult to ascertain if the drugs are truly the culprits or if they are simply correlated with a higher-risk lifestyle.

To overcome these methodological hurdles and obtain a clearer, more definitive picture, researchers from the University of Cambridge Department of Clinical Neurosciences embarked on an ambitious meta-analysis. This comprehensive study aggregated and analyzed data from numerous published cohort studies, encompassing an unprecedented participant pool of over 100 million individuals. A meta-analysis is a powerful statistical technique that systematically combines the results of multiple independent studies addressing the same research question. By pooling data from a vast number of participants, researchers can significantly increase statistical power, detect effects that might be missed in smaller individual studies, and resolve inconsistencies or controversies arising from disparate findings. This approach allowed the Cambridge team to draw far stronger conclusions than would be possible from any single study.

Their meticulous analysis, published in the prestigious International Journal of Stroke, revealed substantial and concerning differences in stroke risk associated with the use of several recreational drugs. Cocaine use emerged with a striking 96% increased risk of stroke, essentially doubling the likelihood for users. Amphetamine use showed an even higher association, linked to a 122% increased risk, translating to more than twice the chance of experiencing a stroke. Cannabis use, while showing a lower magnitude of increase compared to stimulants, was still significantly associated with an approximately 37% elevated risk of stroke. In contrast, the analysis found no statistically significant association between opioid use and stroke risk. This distinction is crucial, suggesting that not all recreational drugs impact cerebrovascular health in the same manner or to the same degree. The term "statistically significant" here implies that the observed risk increase is unlikely to have occurred by random chance, lending considerable weight to the findings.

Heightened Vulnerability in Younger Populations

The study further highlighted a particularly alarming trend: the heightened vulnerability of younger individuals to drug-induced strokes. When the researchers specifically examined participants under the age of 55, the risks associated with certain drugs became even more pronounced. In this younger demographic, amphetamine use was linked to a nearly threefold increase in stroke risk, an astounding 174% rise. Cocaine use maintained a high association, with a 97% increase in stroke risk, nearly doubling it. Cannabis use, while showing a comparatively smaller increase than for the general population in this specific age group, still presented a significant 14% elevation in stroke risk.

Stroke in younger individuals, though less common than in older adults, carries particularly devastating consequences. A stroke at a young age can lead to decades of disability, profoundly impacting education, career progression, family life, and overall independence. The long-term societal and personal costs are immense, making these findings regarding younger users especially critical for public health initiatives.

To move beyond mere associations and investigate whether these relationships might indeed be causal, the research team employed Mendelian randomization. This innovative statistical method leverages naturally occurring genetic variants as "instrumental variables" to assess the causality of observed associations between risk factors and health outcomes. Because genetic variants are randomly assigned at conception, similar to how participants are randomly assigned to treatment groups in a clinical trial, Mendelian randomization can largely circumvent the problem of confounding factors that plague traditional observational studies. By examining genetic predispositions linked to certain behaviors (like substance use disorders) and their correlation with stroke outcomes, researchers can infer whether evidence supports a causal relationship.

The genetic analysis provided compelling support for causality. It found that cocaine use disorders were strongly and causally associated with specific types of stroke: brain hemorrhage (intracerebral hemorrhage, a bleeding into the brain tissue) and cardioembolic stroke (where a blood clot forms in the heart, often due to abnormal rhythms like atrial fibrillation, and then travels to the brain, blocking blood flow). Cannabis use disorders were causally associated with stroke overall, and particularly linked to large artery stroke, which often involves atherosclerosis (hardening and narrowing of the major arteries supplying the brain). Problematic alcohol use was also causally associated with an increased risk of both cardioembolic stroke and large artery stroke, with alcohol addiction linked to a greater overall risk of stroke. These genetic findings significantly bolster the argument that it is the drugs themselves, rather than merely co-occurring lifestyle factors, that are driving the increased stroke risk.

It’s important to note that the researchers were unable to perform the same Mendelian randomization analysis for amphetamine use. This limitation was due to the current unavailability of sufficiently large genetic datasets containing information specifically about amphetamine use, highlighting a gap in existing genetic research resources. Despite this, the strong associations observed in the meta-analysis for amphetamines, particularly in younger populations, remain a significant concern.

Understanding the Biological Mechanisms of Drug-Induced Stroke

The study also delved into the plausible biological mechanisms through which these substances could precipitate a stroke. Recreational drugs can exert a myriad of physiological effects that directly compromise cerebrovascular health. The researchers highlighted several key pathways:

1. Sudden Increases in Blood Pressure (Hypertensive Crisis): Stimulants like cocaine and amphetamines are potent vasoconstrictors and sympathetic nervous system activators. They can cause abrupt and severe spikes in blood pressure, leading to a hypertensive crisis. This sudden pressure surge can overwhelm the integrity of blood vessels in the brain, making them more susceptible to rupture, thereby causing a hemorrhagic stroke (brain bleed).

2. Vasospasm and Vasoconstriction: Many recreational drugs, especially stimulants and, to some extent, cannabis, can induce vasospasm—a sudden, transient narrowing of blood vessels—or sustained vasoconstriction. This narrowing restricts blood flow to parts of the brain, leading to ischemia (lack of oxygen and nutrients). If prolonged, this can result in an ischemic stroke. The mechanisms involve direct effects on vascular smooth muscle and modulation of neurotransmitters like norepinephrine and serotonin.

3. Abnormal Heart Rhythms (Arrhythmias): Stimulants can directly affect cardiac function, leading to a range of arrhythmias, including atrial fibrillation. Atrial fibrillation is a major independent risk factor for cardioembolic stroke, as it causes blood to pool and clot in the heart’s upper chambers. These clots can then dislodge and travel to the brain, blocking cerebral arteries.

4. Increased Blood Clotting (Thrombogenicity): Cannabis, in particular, has been implicated in increasing blood coagulability. While the exact mechanisms are still being fully elucidated, some studies suggest cannabis use can affect platelet aggregation and other components of the clotting cascade, making blood more prone to clot formation. These clots can then block blood vessels in the brain, causing ischemic stroke.

5. Inflammation and Vasculitis: Chronic use of certain drugs, especially amphetamines, can induce systemic inflammation and even vasculitis—inflammation of the blood vessel walls. This inflammatory process can damage the inner lining of blood vessels, making them more susceptible to clot formation, plaque rupture, or direct occlusion, leading to both ischemic and hemorrhagic strokes.

All these physiological processes—elevated blood pressure, compromised vascular integrity, cardiac dysfunction, and altered blood clotting—are well-established contributors to stroke pathology. They can independently or synergistically lead to either ischemic strokes (caused by blood clots interrupting blood flow) or hemorrhagic strokes (caused by bleeding into the brain). The Mendelian randomization analysis provided further granular insights, linking cocaine specifically to brain hemorrhage and cardioembolic stroke, and cannabis to large artery stroke, suggesting distinct pathways for different substances.

Dr. Megan Ritson from the Stroke Research Group at the University of Cambridge emphasized the significance of these findings, stating: "This is the most comprehensive analysis ever conducted on recreational drug use and stroke risk and provides compelling evidence that drugs like cocaine, amphetamines, and cannabis are causal risk factors for stroke. These findings give us stronger evidence to guide future research and public health strategies."

Dr. Eric Harshfield, Alzheimer’s Society Research Fellow at the Department of Clinical Neurosciences, further underscored the study’s impact: "Our analysis suggests that it is these drugs themselves that increase the risk of stroke, not just other lifestyle factors among users. Taken together, our findings emphasize the importance of public health measures to reduce substance abuse as a way of helping also reduce stroke risk."

The implications of this research are far-reaching. For public health, the study provides robust data to inform targeted prevention campaigns, especially those aimed at younger populations who might underestimate the severe risks associated with recreational drug use. Healthcare providers should consider routine screening for substance use in patients presenting with stroke, particularly those in younger age groups or without traditional risk factors. Furthermore, these findings could influence policy discussions around drug regulation and harm reduction strategies, emphasizing the need for comprehensive approaches that address the health consequences of substance abuse. The study’s clear demonstration of causality moves the conversation from mere correlation to a direct understanding of how these substances contribute to the global burden of stroke, reinforcing the urgent need for effective interventions.

This vital study was made possible through funding from the British Heart Foundation, with additional support from the National Institute for Health and Care Research Cambridge Biomedical Research Center, highlighting the collaborative effort required to tackle complex health challenges.